Skip to main content
. 2013 Feb 5;138(3):208–215. doi: 10.1111/imm.12029

Figure 3.

Figure 3

Addition of freshly activated encephalitogenic cells exacerbates chronic classical experimental autoimmune encephalomyelitis (cEAE) disease regardless of the capacity of new cells to produce interferon‐γ (IFN‐γ). Mice received 5 × 106 wild‐type MOG35–55‐specific CD4+ T cells (where MOG35–55 is a peptide comprising amino acids 35 to 55 of the myelin oligodendrocyte glycoprotein). After 23 days (a) or 90 days (b) mice received 5 × 106 of an IFN‐γ‐deficient MOG35–55‐specific cell line (●), an IFN‐γ‐sufficient ovalbuminspecific cell line (▲), or the initially injected IFN‐γ‐sufficient MOG35–55‐specific T‐cell line (■). Mice were then followed for the clinical symptoms of cEAE over time. Results shown were collected from eight mice (a) or 10–12 mice (b) in each group examined over two experiments.